Self Study Module 1: First-Line Treatment of Advanced, Recurrent and Metastatic Cervical Cancer

Primary Audience:

This activity is intended to meet the educational needs of healthcare professionals involved in the care of patients with cervical cancer.

This module will cover the first-line treatment of advance, recurrent, and metastatic cervical cancer.

Stéphanie Gaillaird, MD, PhD

Stéphanie Gaillard, MD, PhD
Assistant Professor, Oncology and Gynecology/Obstetrics
Director of Gynecologic Cancer Trials
Director of Developmental Therapeutics
Johns Hopkins Hospital
Baltimore, MD

Stéphanie Gaillard is a medical oncologist who specializes in the treatment of gynecologic malignancies. She recently joined the faculty of the Johns Hopkins Sidney Kimmel Comprehensive Cancer Center and is their Director of Gynecologic Cancer Trials. Dr. Gaillard earned her medical degree and doctoral degree in cancer biology from Duke University. Following medical school, she underwent residency training in Internal Medicine and fellowship training in Medical Oncology at the Johns Hopkins School of Medicine. She is board certified in Medical Oncology and Internal Medicine. Dr. Gaillard’s research focuses on the development of clinical trials aimed at improving outcomes by incorporating promising new biologic, targeted, and immune therapies into standard treatment regimens. Her translational research program focuses on understanding the immune environment associated with gynecologic cancers and mechanisms of resistance to current therapies.

Kimberly Levinson, MD, MPH

Kimberly Levinson, MD, MPH
Associate Professor of Gynecology and Obstetrics
Director of the Johns Hopkins Gynecologic Oncology Program at Greater Baltimore Medical Center
Johns Hopkins University
Baltimore, MD

Kimberly Levinson, M.D., is an assistant professor in the Johns Hopkins Medicine Department of Gynecology and Obstetrics. Her areas of clinical expertise include minimally invasive surgery with both robotic and single incision laparoscopy, ovarian cancer debulking, cervical cancer and dysplasia. Dr. Levinson has nine years of experience in clinical medicine and five years of experience in academic medicine. 

Dr. Levinson received her undergraduate degree from Tufts University. She earned her M.D. from the Johns Hopkins University School of Medicine and her M.P.H. from the Johns Hopkins Bloomberg School of Public Health. She completed her medical residency at the Johns Hopkins University School of Medicine and performed a clinical fellowship in gynecologic oncology at Cleveland Clinic. Dr. Levinson has also completed international research at Preventive Oncology International in Peru and the School for International Training in Chile. Dr. Levinson joined the Johns Hopkins faculty in 2014.

Her research interests include health care disparities in gynecologic tumors, cervical cancer prevention and treatment, and surgical innovation. She has published numerous manuscripts in gynecologic oncology involving these and other various research topics. In addition, she has a strong commitment to education, and she is the assistant director of the Johns Hopkins residency program.

Dr. Levinson is a member of the American College of Obstetricians and Gynecologists, the Society of Gynecologic Oncology, and the American Medical Association. She is the director of the Gynecologic Oncology Fellows Research Network. Dr. Levinson was recognized with a Robert B. Hunt Award for Best Paper Published in the Journal of Minimally Invasive Gynecology in 2014.
1.
Employ current evidence and best practices to the determination of patient/treatment factors when choosing subsequent treatments of advanced cervical cancer.